SCHEMBL27232175

SCHEMBL27232175

Cc1c(S(=O)(=O)N[C@H](CCCNC(=N)N)C(=O)O)ccc2c1C(C)(C)C(C)(C)O2

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.43
ITGA2B P08514 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.38
MMP2 P08253 10/20 0.34
MMP9 P14780 10/20 0.34
MMP8 P22894 4/20 0.34
MMP12 P39900 4/20 0.34
MMP14 P50281 4/20 0.34
BMP1 P13497 2/20 0.33
MMP1 P03956 1/20 0.33
MMP3 P08254 1/20 0.33
MMP7 P09237 1/20 0.33
MMP13 P45452 1/20 0.33
ITGAV P06756 2/20 0.32
ALDH1A1 P00352 1/20 0.31
CYP2C19 P33261 1/20 0.31
ITGA2 P17301 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8998756 0.80 ITGB3 (0.49) ITGB3ITGA2BL3MBTL1MMP2MMP9
SCHEMBL6877985 0.75 ITGAV (0.57) ITGB3ITGA2BL3MBTL1MMP2MMP9
SCHEMBL8492995 0.75 ITGAV (0.57) ITGB3ITGA2BL3MBTL1MMP2MMP9
SCHEMBL7262680 0.74 ITGB3 (0.45) ITGB3ITGA2BL3MBTL1MMP2MMP9
SCHEMBL1509767 0.73 ITGB3 (0.71) ITGB3ITGA2BMMP2MMP9MMP8
SCHEMBL1509766 0.73 ITGB3 (0.71) ITGB3ITGA2BMMP2MMP9MMP8
SCHEMBL9293208 0.73 ITGB3 (0.71) ITGB3ITGA2BMMP2MMP9MMP8
SCHEMBL28235262 0.73 ITGB3 (0.43) ITGB3ITGA2BMMP2MMP9MMP8
SCHEMBL7420368 0.72 SLC1A3 (0.53) ITGB3ITGA2BITGAV
SCHEMBL7420373 0.72 SLC1A3 (0.53) ITGB3ITGA2BITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240173309-A1 LIPIDATED PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR JANSSEN RESEARCH & DEVELOPMENT, LLC 2024-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240173309-A1 LIPIDATED PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR IL23R, IL1RN, IL36G ITGB3 1798/4885ITGA2B 4006/4885L3MBTL1 3505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.